Auris Medical Holding Investor Presentation — June 2021

Document content

Company Presentation

2021 LD Micro Invitational XI –June 9, 2021

Forward-looking Statements

This presentation may contain statements

that constitute “forward -looking statements”

within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward- looking statements are statements

other than historical facts and may include statements that address future operating, financial or business performance or Auris Medical’s strategies or expectations. In some cases, you can identify these statements by forward- looking words such

as “may”, “might”, “will”, “should”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “projects”, “potential”, “outlook” or “continue”, or the negative of these terms or other comparable terminology. Forward-looking statements are based on management’s current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements. These risks and uncertainties include, but are not limited to, the approval and timing of commercialization of AM -301, Auris Medical’s need for and

ability to raise substantial additional funding

to continue the development of its product

candidates, the timing and conduct of

clinical trials of Auris Medical’s product

candidates, the clinical utility of Auris

Medical’s product candidates, the timing or

likelihood of regulatory filings and approvals,

Auris Medical’s intellectual property position

and Auris Medical’s financial position,

including the impact of any future acquisitions, dispositions, partnerships,

license transactions or changes to Auris

Medical’s capital structure, including future

securities offerings. These risks and

uncertainties also include, but are not limited

to, those described under the caption “Risk

Factors” in Auris Medical’s Annual Report on

Form 20- F for the year ended December 31,

2020, and in Auris Medical's other filings

with the SEC, which are available free of charge on the Securities Exchange Commission's website at: www.sec.gov.

Should one or more of these risks or uncertainties materialize, or should

underlying assumptions prove incorrect, actual results may vary materially from those indicated. All forward- looking statements

and all subsequent written and oral forward-looking statements attributable to Auris Medical or to persons acting on behalf of Auris Medical are expressly qualified in their entirety by reference to these risks and uncertainties. You should not place undue reliance on forward- looking statements.